Moderna begins study for omicron-specific booster shot

Moderna Inc. announced Wednesday that it had begun its first study of an omicron-specific booster dose of its COVID-19 vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.